Cite

HARVARD Citation

    Rubino, C. et al. (n.d.). 591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants. Open forum infectious diseases. p. . [Online]. 
  
Back to record